JPMorgan Chase & Co’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.1K | Buy |
+27,698
| New | +$75.1K | ﹤0.01% | 4919 |
|
|
2024
Q4 | – | Sell |
-97
| Closed | -$242 | – | 6365 |
|
|
2024
Q3 | $242 | Buy |
97
+6
| +7% | +$15 | ﹤0.01% | 5812 |
|
|
2024
Q2 | $240 | Buy |
91
+35
| +63% | +$92 | ﹤0.01% | 5740 |
|
|
2024
Q1 | $115 | Sell |
56
-934
| -94% | -$1.92K | ﹤0.01% | 5869 |
|
|
2023
Q4 | $1.78K | Buy |
990
+964
| +3,708% | +$1.74K | ﹤0.01% | 5702 |
|
|
2023
Q3 | $36 | Buy |
+26
| New | +$36 | ﹤0.01% | 6089 |
|
|
2021
Q4 | – | Sell |
-20
| Closed | – | – | 5748 |
|
|
2021
Q3 | $0 | Sell |
20
-46
| -70% | – | ﹤0.01% | 5562 |
|
|
2021
Q2 | $1K | Buy |
+66
| New | +$1K | ﹤0.01% | 5406 |
|
|
2020
Q2 | – | Sell |
-6
| Closed | – | – | 4781 |
|
|
2020
Q1 | $0 | Buy |
+6
| New | – | ﹤0.01% | 4689 |
|
|
2017
Q2 | – | Sell |
-660
| Closed | -$89K | – | 4367 |
|
|
2017
Q1 | $89K | Sell |
660
-49
| -7% | -$6.61K | ﹤0.01% | 3767 |
|
|
2016
Q4 | $112K | Buy |
709
+77
| +12% | +$12.2K | ﹤0.01% | 3852 |
|
|
2016
Q3 | $157K | Buy |
632
+31
| +5% | +$7.7K | ﹤0.01% | 3324 |
|
|
2016
Q2 | $537K | Sell |
601
-12
| -2% | -$10.7K | ﹤0.01% | 2962 |
|
|
2016
Q1 | $557K | Buy |
613
+26
| +4% | +$23.6K | ﹤0.01% | 2887 |
|
|
2015
Q4 | $828K | Sell |
587
-583
| -50% | -$822K | ﹤0.01% | 2740 |
|
|
2015
Q3 | $1.96M | Buy |
1,170
+93
| +9% | +$156K | ﹤0.01% | 2382 |
|
|
2015
Q2 | $2.32M | Sell |
1,077
-101
| -9% | -$218K | ﹤0.01% | 2445 |
|
|
2015
Q1 | $2.16M | Sell |
1,178
-30
| -2% | -$54.9K | ﹤0.01% | 2492 |
|
|
2014
Q4 | $2.88M | Sell |
1,208
-19
| -2% | -$45.4K | ﹤0.01% | 2325 |
|
|
2014
Q3 | $3.01M | Buy |
+1,227
| New | +$3.01M | ﹤0.01% | 2237 |
|